About TAGCyx
TAGCyx is a Healthcare company based in Yokohama (Japan) founded in 2007. Provider of nucleic acid-based drug discovery platform. TAGCyx has raised $4.9 million across 2 funding rounds from investors including SBI Group, UTokyo Innovation Platform and Healthcare Innovation. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
TAGCyx was founded in 2007 in Yokohama, Japan, as a biotechnology firm focused on nucleic acid therapeutics. A platform called Xenoligo is utilized to screen extensive libraries of oligonucleotides incorporating non-natural bases, through a modified SELEX process involving selection and PCR amplification cycles. A pipeline of drug candidates has been developed targeting autoimmune diseases, hematology, and nephrology indications. Operations center on advancing these candidates toward clinical applications.
- Headquarters Yokohama, Japan
- SectorsHealthcare
- Email••••••••
- Website tagcyx.com
- Social LinkedIn
- Total Equity Funding$4.9M (USD)
in 2 rounds
- InvestorsSBI Group
& 5 more
Funding Insights of TAGCyx
TAGCyx has successfully raised a total of $4.9M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.9M
- Total Rounds 2
- First Round $4.9M
(Aug 2016)
- Investors Count 6
All 2 funding rounds of TAGCyx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | Series B | – | UTokyo Innovation Platform, SBI Group | – | |
| Aug 2016 | $4.9M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in TAGCyx
TAGCyx has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include SBI Group, UTokyo Innovation Platform and Healthcare Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Accelerator and venture capital services are provided by UTokyo-backed platform. | utokyo-ipc.co.jp | Bunkyo, Japan | ||
Investment fund focused on biotech and healthcare ventures in Japan. | hcinnovation.jp | Japan | ||
Seed and Early stage VC firm investing in Japan | ut-ec.co.jp | Tokyo, Japan | ||
Venture capital firm investing in biotech, adtech sectors | nissay-cap.co.jp | Chiyoda City, Japan | ||
| smbc-vc.co.jp | ||||
Diversified operations in finance, biotech, and healthcare are managed. | 1999 | sbigroup.co.jp | Tokyo, Japan |
Investor details for TAGCyx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TAGCyx
4 people are tracked at TAGCyx (4 in leadership).
| Name | Role | Group |
|---|---|---|
Chizuko Koseki | President & CEO | Leadership |
Gen Watanabe | Director COO | Leadership |
Koichiro Kasahara | CFO & Administration Division, Vice President | Leadership |
Miyuki Hori | Drug Discovery And Development Division, Vice President | Leadership |
Complete people profiles for TAGCyx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TAGCyx
3 dated milestones of TAGCyx across 14 years, from founding to its latest funding, stage changes and deals.
- Founded TAGCyx is founded.
- Funding First funding round of $4.9M.
- Funding Latest funding round, Series B,.
Web traffic of TAGCyx
The website of TAGCyx (tagcyx.com) receives about 2K visits a month.
- Monthly visits2K
▼ 4.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tagcyx
Complete news archive for TAGCyx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TAGCyx
TAGCyx was founded in 2007 and raised its 1st funding round 9 years after it was founded.
TAGCyx is headquartered in Yokohama, Japan. It is registered at Yokohama, Kanagawa, Japan.
TAGCyx is a funded company, having raised a total of $4.9M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.9M, raised on Aug 2016.
TAGCyx was founded in 2007 in Yokohama, Japan, as a biotechnology firm focused on nucleic acid therapeutics. A platform called Xenoligo is utilized to screen extensive libraries of oligonucleotides incorporating non-natural bases, through a modified SELEX process involving selection and PCR amplification cycles. A pipeline of drug candidates has been developed targeting autoimmune diseases, hematology, and nephrology indications. Operations center on advancing these candidates toward clinical applications.
TAGCyx has 6 investors. Key investors include SBI Group, UTokyo Innovation Platform, Healthcare Innovation, UT-EC Japan, and Nissay Capital.